Clinical & Translational Oncology

期刊全称Clinical & Translational Oncology
期刊缩写CLIN TRANSL ONCOL
涉及主题医学生物内科学遗传学癌症病理外科肿瘤科化学生物化学放射科癌症研究免疫学基因化疗数学
期刊介绍

Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.

期刊ISSNprint: 1699-048
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
2.83.43.343.4052.7372.4412.3922.353
历年发表/被引量
年份20252024202320222021202020192018201720162015201420132012
发表量162450305298217246244185217123200112174224
被引量26635888660264095944503537863112289825252394214718371495
h-Index42
自引率3.60%
涉及的研究领域医学-肿瘤学
中科院2025年分区 ?
大类小类TOP期刊综述期刊
4区4区 肿瘤学
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
ONCOLOGYSCIEQ3188/326

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
ONCOLOGYSCIEQ3190/326
期刊主页https://www.springer.com/12094https://link.springer.com/journal/12094
投稿网址https://www.editorialmanager.com/clat/
出版商Springer International Publishing
出版国家(地区)SPAIN
出版语言English
出版周期Monthly
每年出版文章数205
Gold OA文章占比21.58%
原创研究文献占比
(排除综述)
69.15%
SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1699-048X%5BISSN%5D
平均审稿周期平均2.2月
平均录用比例约50%
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈